website: 86th General Session & Exhibition of the IADR

ABSTRACT: 1558  

Serum Bone-Resorption Biomarkers: Correlation with Alveolar and Systemic Bone Changes

J.B. PAYNE1, J.A. STONER2, H.M. LEE3, P.V. NUMMIKOSKI4, R.A. REINHARDT1, R. VALENTE5, and L.M. GOLUB3, 1University of Nebraska Medical Center College of Dentistry, Lincoln, USA, 2University of Oklahoma Health Sciences Center, Oklahoma City, USA, 3Stony Brook University, NY, USA, 4University of Texas, San Antonio, USA, 5Arthritis Center of Nebraska, Lincoln, USA

Objective: To examine the association between serum bone resorption biomarkers and alveolar and systemic bone loss. Methods: 128 postmenopausal osteopenic, estrogen-deficient women on periodontal maintenance therapy for moderate-advanced periodontitis participated in a two-year randomized, double-blind, placebo-controlled, clinical trial examining the efficacy/safety of subantimicrobial dose doxycycline (SDD; 20 mg bid). Posterior vertical bite-wings were taken at baseline, one and two years for alveolar bone density and height (ABD and ABH). ABD and systemic bone mineral density (BMD) were determined by computer-assisted densitometric image analysis (CADIA) and dual-energy x-ray absorptiometry, respectively. ABH was determined by the method of Hausmann et al. Serum type I collagen bone resorption markers, CTx (ELISA) and ICTP (RIA), also were measured. This abstract presents secondary analyses (using Generalized Estimating Equations) from this trial; namely, concurrent changes between serum biomarkers and alveolar and systemic bone loss at one and two years. Results: Increases in serum CTx were associated with ABD loss (p=0.01) regardless of treatment and time, while the association between serum ICTP and ABD loss was not significant (p=0.2). Regarding ABH, there was no significant association between serum CTx and ABH loss (p=0.9). However, increases in serum ICTP over two years were associated with ABH loss (p=0.005) regardless of treatment. Increases in serum CTx were associated with lumbar spine BMD loss at two years (p=0.001); this association was driven primarily by placebo subjects. The association between serum CTx and femoral BMD loss at two years was not significant (p=0.2). No significant association was found between serum ICTP and systemic BMD loss. Conclusions: These data suggest that, in this postmenopausal subject population, ABD and ABH loss, like systemic BMD, may reflect, in part, biomarkers of systemic bone turnover. Supported by NIDCR grant R01DE012872.

Back to Top